bf/NASDAQ:ADAP_icon.png

NASDAQ:ADAP

Adaptimmune Therapeutics plc

  • Stock

USD

Last Close

0.05

27/10 22:32

Market Cap

293.91M

Beta: 2.24

Volume Today

564.86K

Avg: 683.17K

PE Ratio

−1.68

PFCF: −2.03

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.04
-
0.06
69.79%
0.13
122.27%
0.22
59.79%
0.01
97.13%
0.01
41.95%
0.01
49.27%
0.08
530.27%
0.21
159.42%
cash conversion cycle
-17.98
-
cash per share
7.95
-
2.56
67.74%
2.37
7.62%
2.11
11.06%
0.85
59.50%
2.58
202.99%
2.37
8.22%
1.27
46.49%
0.73
42.42%
company equity multiplier
1.16
-
1.41
21.87%
1.39
1.87%
1.12
19.07%
1.47
31.00%
1.32
9.96%
2.28
72.43%
4.02
76.21%
7.15
78.05%
days of inventory outstanding
days of payables outstanding
300.97
-
days of sales outstanding
185.39
-
38.05
79.48%
1.99
94.78%
1.18
40.74%
-474.63
40,400.89%
12.82
102.70%
44.64
248.24%
99.96
123.94%
283.00
183.10%
dividend yield
ebit per revenue
-2.15
-
-5.13
138.30%
-2.13
58.42%
-1.38
35.08%
-124.57
8,899.78%
-33.71
72.94%
-26.39
21.72%
-6.04
77.11%
-2.28
62.31%
ebt per ebit
1.03
-
0.97
5.47%
0.86
11.02%
1.15
33.53%
0.98
15.08%
0.97
0.58%
0.97
0.46%
0.99
2.51%
0.93
6.10%
effective tax rate
0.09
-
-0.01
114.20%
-0.01
48.71%
-0.01
19.18%
-0.00
66.21%
-0.00
29.45%
-0.01
303.32%
-0.02
204.71%
0.11
823.87%
enterprise value multiple
-19.55
-
-1.84
90.59%
-8.34
353.36%
-8.43
1.04%
-0.77
90.90%
-5.84
661.77%
-2.95
49.43%
-0.95
67.75%
-0.32
66.60%
fixed asset turnover
1.99
-
0.51
74.41%
0.93
82.75%
1.65
77.15%
0.02
98.69%
0.08
292.07%
0.12
41.11%
0.38
217.04%
0.84
122.37%
free cash flow per share
-1.06
-
-0.86
18.58%
-0.90
4.76%
-1.12
24.18%
-1.10
1.70%
-0.40
63.98%
0.01
103.15%
-1.06
8,609.36%
-0.73
31.60%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
0.84
16.29%
interest coverage
45.39
-
-36.17
-
-219.06
505.61%
162.99
-
inventory turnover
long term debt to capitalization
0.16
-
0.06
63.09%
0.10
74.76%
0.20
97.02%
0.33
67.99%
net income per ebt
0.91
-
1.01
11.14%
1.01
0.61%
1.01
0.12%
1.00
0.34%
1.00
0.05%
1.01
0.38%
1.02
1.02%
0.89
12.43%
net profit margin
-2.01
-
-5.04
150.37%
-1.85
63.23%
-1.61
13.42%
-122.25
7,516.17%
-32.87
73.11%
-25.71
21.78%
-6.09
76.29%
-1.89
69.01%
operating cash flow per share
-0.91
-
-0.68
25.62%
-0.62
9.23%
-1.07
73.54%
-1.07
0.00%
-0.38
64.90%
0.07
118.31%
-0.88
1,377.09%
-0.70
20.02%
operating cycle
283.00
-
operating profit margin
-2.15
-
-5.13
138.30%
-2.13
58.42%
-1.38
35.08%
-124.57
8,899.78%
-33.71
72.94%
-26.39
21.72%
-6.04
77.11%
-2.28
62.31%
payables turnover
1.21
-
pretax profit margin
-2.21
-
-4.98
125.28%
-1.84
63.00%
-1.60
13.31%
-122.03
7,542.50%
-32.83
73.10%
-25.58
22.07%
-6.00
76.54%
-2.12
64.60%
price fair value
2.53
-
1.73
31.71%
2.89
67.72%
2.27
21.62%
1.02
55.08%
2.25
120.88%
2.84
26.06%
2.87
1.33%
4.04
40.38%
receivables turnover
1.97
-
9.59
387.26%
183.66
1,814.42%
309.92
68.75%
-0.77
100.25%
28.47
3,802.74%
8.18
71.28%
3.65
55.34%
1.29
64.68%
return on assets
-0.07
-
-0.31
325.10%
-0.25
18.27%
-0.35
38.35%
-0.76
118.91%
-0.29
61.83%
-0.34
16.76%
-0.50
49.41%
-0.40
19.59%
return on capital employed
-0.08
-
-0.37
345.02%
-0.39
4.06%
-0.33
16.29%
-0.95
190.85%
-0.32
65.90%
-0.40
23.13%
-0.62
55.56%
-0.66
5.88%
return on equity
-0.08
-
-0.43
418.08%
-0.35
19.80%
-0.39
11.96%
-1.11
186.76%
-0.38
65.64%
-0.77
101.33%
-2.02
163.27%
-2.89
43.17%
total debt to capitalization
0.09
-
0.17
-
0.06
61.95%
0.11
69.37%
0.22
99.80%
0.39
77.26%

All numbers in USD (except ratios and percentages)